GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Return-on-Tangible-Asset

CLS Holdings USA (XCNQ:CLSH) Return-on-Tangible-Asset : -189.12% (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. CLS Holdings USA's annualized Net Income for the quarter that ended in Feb. 2024 was C$-23.59 Mil. CLS Holdings USA's average total tangible assets for the quarter that ended in Feb. 2024 was C$12.47 Mil. Therefore, CLS Holdings USA's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2024 was -189.12%.

The historical rank and industry rank for CLS Holdings USA's Return-on-Tangible-Asset or its related term are showing as below:

XCNQ:CLSH' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2534.38   Med: -258.86   Max: -19.68
Current: -96.98

During the past 11 years, CLS Holdings USA's highest Return-on-Tangible-Asset was -19.68%. The lowest was -2534.38%. And the median was -258.86%.

XCNQ:CLSH's Return-on-Tangible-Asset is ranked worse than
90.77% of 1084 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs XCNQ:CLSH: -96.98

CLS Holdings USA Return-on-Tangible-Asset Historical Data

The historical data trend for CLS Holdings USA's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Return-on-Tangible-Asset Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -259.99 -192.71 -126.90 -20.15 -121.59

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.12 -128.80 -19.69 -53.99 -189.12

Competitive Comparison of CLS Holdings USA's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Return-on-Tangible-Asset falls into.



CLS Holdings USA Return-on-Tangible-Asset Calculation

CLS Holdings USA's annualized Return-on-Tangible-Asset for the fiscal year that ended in May. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: May. 2023 )  (A: May. 2022 )(A: May. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: May. 2023 )  (A: May. 2022 )(A: May. 2023 )
=-18.653/( (18.105+12.576)/ 2 )
=-18.653/15.3405
=-121.59 %

CLS Holdings USA's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=-23.592/( (13.627+11.322)/ 2 )
=-23.592/12.4745
=-189.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2024) net income data.


CLS Holdings USA  (XCNQ:CLSH) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


CLS Holdings USA Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.